Ukoniq Alternatives Compared
Ukoniq | Rituximab | Rituxan |
|
---|
Ukoniq (umbralisib) | Rituximab | Rituxan (rituximab) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Follicular Lymphoma, Marginal Zone Lymphoma. Ukoniq may also be used for purposes not listed in this medication guide. |
Prescription only
Rituximab is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid... View more |
Prescription only
Rituxan is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid... View more |
||||||||
More about Ukoniq (umbralisib) | More about Rituximab | More about Rituxan (rituximab) | ||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Rituximab has an average rating of 7.7 out of 10 from a total of 149 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 14% reported a negative effect. |
Rituxan has an average rating of 8.3 out of 10 from a total of 44 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 12% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: Ukoniq side effects in more detail. |
See also: rituximab side effects in more detail. |
See also: Rituxan side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Rituxan prices |
||||||||
Dosage Form(s) Available | ||||||||||
|
N/A |
|
||||||||
Brand Names | ||||||||||
N/A |
Riabni, Rituxan, Ruxience, Truxima | Other rituximab brands include: Riabni, Ruxience, Truxima | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
91 hours |
59.8 hours |
59.8 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 187 drugs are known to interact with Ukoniq:
|
A total of 170 drugs are known to interact with rituximab:
|
A total of 170 drugs are known to interact with Rituxan:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
February 05, 2021 |
N/A |
N/A |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.